 |
|
|
| |
HAART Initiation and Clinical Outcomes: insights from the CASCADE Cohort on 'When To Start'
|
| |
| |
Reported by Jules Levin
18th Intl AIDS Conference July 18-23 2010, Vienna Austria
Joe Eron, MD, UNC presented the data.
From Jules: OF PARTICULAR note the Limitations slide below says "outcomes do not reflect serious, non-AIDS diagnoses". Which is important because that is a big part of the reason many Guidelines committees are recommending earlier therapy, including considering starting HAART when CD4 are over 500. Here in Vienna the IAS_USA Panel issued their new Guidelines recommending therapy when CD4s are over 500, read reports:
New Guidelines Urge Earlier Therapy for HIV Patients - (07/19/10)
IAC: 'Start HIV Therapy Earlier, IAS-USA Panel Recommends' - (07/20/10)
|
| |
|
|
|
|
|
